We first utilized WB to assess the changes in protein levels of total PI3K, phosphorylated PI3K (P-PI3K), total AKT, and phosphorylated AKT (P-AKT) in GC cells with various genetic manipulations of E2F1, E2F7, and MYBL2. The gene discussed is E2F1; the disease is gastric cancer.